BrainsWay Valuation
| BRSYF Stock | USD 3.15 0.00 0.00% |
At this time, the firm appears to be overvalued. BrainsWay shows a prevailing Real Value of $2.89 per share. The current price of the firm is $3.15. Our model approximates the value of BrainsWay from analyzing the firm fundamentals such as profit margin of (0.37) %, and Return On Equity of -0.2 as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that BrainsWay's price fluctuation is very risky at this time. Calculation of the real value of BrainsWay is based on 3 months time horizon. Increasing BrainsWay's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the BrainsWay pink sheet is determined by what a typical buyer is willing to pay for full or partial control of BrainsWay. Since BrainsWay is currently traded on the exchange, buyers and sellers on that exchange determine the market value of BrainsWay Pink Sheet. However, BrainsWay's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 3.15 | Real 2.89 | Hype 3.15 | Naive 2.92 |
The real value of BrainsWay Pink Sheet, also known as its intrinsic value, is the underlying worth of BrainsWay Company, which is reflected in its stock price. It is based on BrainsWay's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of BrainsWay's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of BrainsWay helps investors to forecast how BrainsWay pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of BrainsWay more accurately as focusing exclusively on BrainsWay's fundamentals will not take into account other important factors: BrainsWay Total Value Analysis
BrainsWay is currently anticipated to have takeover price of (24.98 M) with market capitalization of 35.72 M, debt of 754 K, and cash on hands of 52.45 M. The negative valuation of BrainsWay may imply that the market is not capable to price the future growth of the company or it is pricing it at zero value. It may also suggest that takeover valuation may not have captured all of the outstanding financial obligations of the company both on and off balance sheet. Investors should thoroughly investigate all of the BrainsWay fundamentals.| Takeover Price | Market Cap | Debt Obligations | Cash |
(24.98 M) | 35.72 M | 754 K | 52.45 M |
BrainsWay Investor Information
About 20.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 0.61. Some equities with similar Price to Book (P/B) outperform the market in the long run. BrainsWay recorded a loss per share of 0.22. The entity had not issued any dividends in recent years. The firm had 1:4 split on the 23rd of May 2011. Based on the key measurements obtained from BrainsWay's financial statements, BrainsWay is not in a good financial situation at this time. It has a very high probability of going through financial hardship in December.BrainsWay Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. BrainsWay has an asset utilization ratio of 39.16 percent. This implies that the Company is making $0.39 for each dollar of assets. An increasing asset utilization means that BrainsWay is more efficient with each dollar of assets it utilizes for everyday operations.BrainsWay Ownership Allocation
BrainsWay holds a total of 33.08 Million outstanding shares. BrainsWay shows 19.83 percent of its outstanding shares held by insiders and 1.11 percent owned by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.BrainsWay Profitability Analysis
The company reported the revenue of 29.66 M. Net Loss for the year was (6.46 M) with profit before overhead, payroll, taxes, and interest of 24.35 M.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates BrainsWay's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in BrainsWay and how it compares across the competition.
About BrainsWay Valuation
The pink sheet valuation mechanism determines BrainsWay's current worth on a weekly basis. Our valuation model uses a comparative analysis of BrainsWay. We calculate exposure to BrainsWay's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of BrainsWay's related companies.Brainsway Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States, Europe, Israel, and internationally. Brainsway Ltd. was founded in 2003 and is headquartered in Jerusalem, Israel. Brainsway operates under Medical Devices classification in the United States and is traded on OTC Exchange. It employs 118 people.
8 Steps to conduct BrainsWay's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates BrainsWay's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct BrainsWay's valuation analysis, follow these 8 steps:- Gather financial information: Obtain BrainsWay's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine BrainsWay's revenue streams: Identify BrainsWay's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research BrainsWay's industry and market trends, including the size of the market, growth rate, and competition.
- Establish BrainsWay's growth potential: Evaluate BrainsWay's management, business model, and growth potential.
- Determine BrainsWay's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate BrainsWay's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
BrainsWay Growth Indicators
Investing in growth stocks can be very risky. If the company such as BrainsWay does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 32.9 M | |
| Retained Earnings | -83.8 M |
Complementary Tools for BrainsWay Pink Sheet analysis
When running BrainsWay's price analysis, check to measure BrainsWay's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BrainsWay is operating at the current time. Most of BrainsWay's value examination focuses on studying past and present price action to predict the probability of BrainsWay's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BrainsWay's price. Additionally, you may evaluate how the addition of BrainsWay to your portfolios can decrease your overall portfolio volatility.
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |